Alpha Modus (AMOD) Sues Walgreens for Patent Infringement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/7/2026
- Wall Street ends sharply lower as chips slide, jobs data fuels rate hike fears
- U.S. economy adds 172,000 jobs in May, topping expectations
- Citi warns global stock markets are the frothiest since 2008
- JPMorgan upgrades Tesla, sets new price target on robotaxi and Optimus potential
- Fed risks fueling a stock bubble by overlooking AI-driven inflation: BCA
- Earthquake of magnitude 7.8 strikes off southern Philippines, tsunami warnings issued
- Wall Street ends sharply lower as chips slide, jobs data fuels rate hike fears
- Marvell Technology and Flex to join S&P 500; others to join S&P MidCap 400 and S&P SmallCap 600
- SpaceX signs $920 million monthly cloud deal with Google
- Target recalls Up & Up baby wipes due to bacterial contamination
Alpha Modus Sues Walgreens for Patent Infringement, Strengthening Its Leadership in AI-Driven Retail Innovation
February 4, 2025 8:00 AM ESTCORNELIUS, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (Company) announced today that its wholly owned subsidiary, Alpha Modus, Corp. (Alpha Modus), has filed a patent infringement lawsuit that also alleges willful infringement against Walgreens Co. (Walgreens) in the United States District Court for the Eastern District of Texas. This legal action underscores Alpha Moduss unwavering commitment to protecting its groundbreaking AI-driven retail technology and further solidifies its leadership in the rapidly evolving retail innovation landscape.
Championing Innovation and Protecting Shareholder Value
Alpha Modus has transformed AI-powered retail engagement... More
